share_log

Progyny, Inc. (NASDAQ:PGNY) Director Norman Payson Sells 6,618 Shares

Progyny, Inc. (NASDAQ:PGNY) Director Norman Payson Sells 6,618 Shares

納斯達克:PGNY董事諾曼·佩森出售6,618股
kopsource ·  2022/08/06 19:12

Progyny, Inc. (NASDAQ:PGNY – Get Rating) Director Norman Payson sold 6,618 shares of the firm's stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $32.27, for a total value of $213,562.86. Following the transaction, the director now directly owns 411,412 shares of the company's stock, valued at approximately $13,276,265.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

納斯達克:PGNY-GET評級)董事諾曼·佩森在8月3日週三的一筆交易中出售了6618股該公司股票。這隻股票的平均售價為32.27美元,總價值為213,562.86美元。交易完成後,董事現在直接持有該公司411,412股股票,價值約13,276,265.24美元。這筆交易是在提交給美國證券交易委員會(Securities&Exchange Commission)的一份文件中披露的,可以通過這個鏈接訪問。

Norman Payson also recently made the following trade(s):

諾曼·佩森最近還進行了以下交易:

Get
到達
Progyny
孕期
alerts:
警報:
  • On Wednesday, July 20th, Norman Payson sold 6,618 shares of Progyny stock. The stock was sold at an average price of $33.40, for a total value of $221,041.20.
  • On Wednesday, July 6th, Norman Payson sold 6,618 shares of Progyny stock. The stock was sold at an average price of $29.38, for a total value of $194,436.84.
  • On Wednesday, June 22nd, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $27.35, for a total value of $181,002.30.
  • On Wednesday, May 25th, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $32.09, for a total value of $212,371.62.
  • On Wednesday, May 11th, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $33.45, for a total value of $221,372.10.
  • 7月20日,星期三,諾曼·佩森出售了6,618股Progyny股票。這隻股票的平均售價為33.40美元,總價值為221,041.20美元。
  • 7月6日,星期三,諾曼·佩森出售了6,618股Progyny股票。股票以29.38美元的平均價格出售,總價值為194,436.84美元。
  • 6月22日,星期三,諾曼·佩森出售了6,618股Progyny股票。這些股票的平均價格為27.35美元,總價值為181,002.30美元。
  • 5月25日,星期三,諾曼·佩森出售了6,618股Progyny股票。這些股票的平均價格為32.09美元,總價值為212,371.62美元。
  • 5月11日,星期三,諾曼·佩森出售了6,618股Progyny股票。這些股票的平均價格為33.45美元,總價值為221,372.10美元。

Progyny Stock Up 38.2 %

Progyny股價上漲38.2%

Shares of NASDAQ:PGNY opened at $41.15 on Friday. The company has a market cap of $3.78 billion, a P/E ratio of 89.46, a P/E/G ratio of 15.71 and a beta of 1.85. Progyny, Inc. has a 52 week low of $25.67 and a 52 week high of $68.32. The business has a fifty day simple moving average of $30.23 and a 200-day simple moving average of $37.34.

納斯達克:PGNY上週五開盤報41.15美元。該公司市值為37.8億美元,市盈率為89.46倍,市盈率為15.71倍,貝塔係數為1.85。Progyny,Inc.的52周低點為25.67美元,52周高點為68.32美元。該業務的50日簡單移動均線切入位為30.23美元,200日簡單移動均線切入位為37.34美元。

Progyny (NASDAQ:PGNY – Get Rating) last issued its earnings results on Thursday, August 4th. The company reported $0.09 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.04. Progyny had a return on equity of 18.11% and a net margin of 7.39%. The firm had revenue of $195.00 million for the quarter, compared to analysts' expectations of $190.51 million. During the same quarter last year, the firm earned $0.19 earnings per share. The firm's revenue for the quarter was up 51.5% compared to the same quarter last year. Sell-side analysts expect that Progyny, Inc. will post 0.09 earnings per share for the current fiscal year.
納斯達克(股票代碼:PGNY-GET Rating)最近一次發佈財報是在8月4日(星期四)。該公司公佈本季度每股收益為0.09美元,比分析師普遍預期的0.05美元高出0.04美元。Progyny的股本回報率為18.11%,淨利潤率為7.39%。該公司當季營收為1.95億美元,高於分析師預期的1.9051億美元。去年同一季度,該公司每股收益為0.19美元。與去年同期相比,該公司本季度的收入增長了51.5%。賣方分析師預計,Progyny,Inc.本財年每股收益將為0.09美元。

Institutional Inflows and Outflows

機構資金流入和流出

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. State Board of Administration of Florida Retirement System boosted its holdings in Progyny by 39.0% in the second quarter. State Board of Administration of Florida Retirement System now owns 14,408 shares of the company's stock valued at $419,000 after acquiring an additional 4,040 shares during the last quarter. Landscape Capital Management L.L.C. acquired a new position in Progyny in the second quarter valued at $442,000. Los Angeles Capital Management LLC boosted its holdings in Progyny by 25.0% in the second quarter. Los Angeles Capital Management LLC now owns 12,536 shares of the company's stock valued at $364,000 after acquiring an additional 2,511 shares during the last quarter. Fort Washington Investment Advisors Inc. OH boosted its holdings in Progyny by 69.2% in the second quarter. Fort Washington Investment Advisors Inc. OH now owns 441,903 shares of the company's stock valued at $12,837,000 after acquiring an additional 180,800 shares during the last quarter. Finally, Kornitzer Capital Management Inc. KS acquired a new position in shares of Progyny during the second quarter worth about $3,167,000. Institutional investors and hedge funds own 82.51% of the company's stock.

一些對衝基金和其他機構投資者最近增持或減持了該公司的股份。佛羅裏達州行政管理委員會退休系統在第二季度將其在Progyny的持有量增加了39.0%。佛羅裏達州行政管理委員會退休系統現在擁有14,408股該公司的股票,價值419,000美元,在上個季度額外購買了4,040股。景觀資本管理公司在第二季度收購了Progyny的一個新頭寸,價值442,000美元。洛杉磯資本管理公司在第二季度將其在Progyny的持股增加了25.0%。洛杉磯資本管理有限責任公司在上個季度增持了2,511股後,現在擁有12,536股該公司股票,價值364,000美元。華盛頓堡投資顧問公司(Fort Washington Investment Advisors Inc.)第二季度將其在Progyny的持股增加了69.2%。華盛頓堡投資顧問公司(Fort Washington Investment Advisors Inc.)目前持有441,903股該公司股票,價值12,837,000美元,此前該公司在上個季度增持了180,800股。最後,Kornitzer Capital Management Inc.KS在第二季度收購了價值約3,167,000美元的Progyny股票。機構投資者和對衝基金持有該公司82.51%的股票。

Progyny Company Profile

Progyny公司簡介

(Get Rating)

(獲取評級)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Progyny,Inc.是一家福利管理公司,專門為美國僱主提供生育和家庭建設福利解決方案。其生育福利解決方案包括差異化福利計劃設計、個性化禮賓式會員支持服務和有選擇的生育專家網絡。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Progyny (PGNY)
  • MarketBeat: Week in Review 8/1 – 8/5
  • How to Use High Beta Stocks to Maximize Your Investing Profits
  • Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
  • Beyond Meat Is Not Beyond Hope, And It's Cheap
  • Why Apple Could Be At All-Time Highs By Year End
  • 免費獲取StockNews.com關於Progyny的研究報告(PGNY)
  • MarketBeat:回顧中的一週8/1-8/5
  • 如何利用高貝塔係數股票最大化你的投資利潤
  • 克羅諾斯集團(Cronos Group Inc.)營收上升,是時候收購了嗎?
  • Beyond Meat不是沒有希望,而且它很便宜
  • 蘋果為何可能在年底創下歷史新高

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.

接受Progyny Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Progyny和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論